UROwebinar: Minimally Invasive Surgical Treatments (MISTs) for Benign Prostatic Obstruction (BPO): Which one to choose?

The scientific programme will focus on the following aspects:

• An evidence-based analysis of current MISTs devices and emerging technologies.
• A review of MISTs as a first-line treatment option to avoid the long-term side effects and costs associated with life-long medication.
• Evaluating the role of MISTs in complex cases with challenging anatomies, such as large prostates, median lobes, urinary retention, and patients receiving anticoagulant therapy.

By integrating the latest evidence and clinical data, this UROwebinar will equip urologists with the knowledge to optimise patient selection, refine treatment algorithms, and deliver patient-centred care that preserves sexual and urinary function.